| # | Drug | Count |
|---|---|---|
| 0 | DOCETAXEL | 22 |
| 1 | DOCETAXEL ANHYDROUS | 22 |
| 2 | LEUPROLIDE ACETATE | 17 |
| 3 | ETOPOSIDE | 15 |
| 4 | ABIRATERONE ACETATE | 12 |
| 5 | BICALUTAMIDE | 12 |
| 6 | ABIRATERONE | 9 |
| 7 | CARBOPLATIN | 8 |
| 8 | DAROLUTAMIDE | 8 |
| 9 | PACLITAXEL | 8 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | DAROLUTAMIDE | 8 | 0.0014 |
| 1 | LAROTRECTINIB | 1 | 0.0011 |
| 2 | CABAZITAXEL | 3 | 0.0009 |
| 3 | BICALUTAMIDE | 12 | 0.0008 |
| 4 | DEGARELIX | 4 | 0.0008 |
| 5 | TRIPTORELIN | 2 | 0.0006 |
| 6 | DOCETAXEL | 22 | 0.0003 |
| 7 | DOCETAXEL ANHYDROUS | 22 | 0.0003 |
| 8 | ABIRATERONE ACETATE | 12 | 0.0003 |
| 9 | LEUPROLIDE ACETATE | 17 | 0.0002 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Androgen Receptor Inhibitor [EPC] | 16 | 0.0002 |
| 1 | Topoisomerase Inhibitor [EPC] | 15 | 0.0002 |
| 2 | Osmotic Diuretic [EPC] | 1 | 0.0002 |
| 3 | Microtubule Inhibitor [EPC] | 30 | 0.0002 |
| 4 | Poly(ADP-Ribose) Polymerase Inhibitor [EPC] | 2 | 0.0001 |
| 5 | Platinum-based Drug [EPC] | 14 | 0.0001 |
| 6 | Programmed Death Ligand-1 Blocker [EPC] | 1 | 0.0000 |
| 7 | Programmed Death Receptor-1 Blocking Antibody [EPC] | 1 | 0.0000 |
| 8 | Interleukin-12 Antagonist [EPC] | 1 | 0.0000 |
| 9 | Interleukin-23 Antagonist [EPC] | 1 | 0.0000 |